The clinic says the choice should weigh long term outcomes and overall health, not just pounds lost, and that no single treatment fits everyone.
Recap by typeshit. Post by @osheahoganlabs on Instagram.
15:25
Doctor Alex says Ozempic works but comes with a catch, and walks through what he thinks people misunderstand about GLP-1 drugs.
Lilly reports on Oct. 29, and Zacks expects investors to focus on Foundayo after the oral GLP-1 brought in $98 million in its first full quarter on sale.
Kalkine Media ties the attention on Lilly to orforglipron's progress, arguing a pill could scale cheaper than injectables and ease supply limits.
Smaller portions could become more common on shelves, with inflation and GLP-1 appetite changes both pushing food makers toward personal packs.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
A Williamsburg shop sells injectable peptide vials for around $95 each, while the FDA has sent warning letters to sellers relying on the same label.
Loading…